Use of antisecretory factor for neuroprotection
CA 2537335 C · Owner: Hansson, Hans-Arne · Inventors: Lonnroth, Ivar; Persson, Anders; Hansson, Hans-Arne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of an antisecretory protein or homologues therof having the same properties or certain fragments thereof in , the manufacture of a medicament or a medical food for inducing improved rescue of injured or diseased nervous tissue, proliferation apoptosis, differentiation and/or migration of an embryonic stem cell adult stem cell, progenitor cell and/or a cell derived from a stem cell or progenitor cell for , treating a condition characterised by or associated with loss and/or gain of cells. In a preferred embodiment, the condition is a neurotrauma or a condition or disease of the CNS and/or PNS and/or ANS for example, Alzheimer's disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 24, 2004 and granted December 5, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 24, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.